History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Cycle for Survival Fred's Team Rock & Run on the River Yankees Universe Fund Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases In the News Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment

Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Lobectomy versus Thoracotomy and Lobectomy

[Protocol 05-006]


Full Title :
QUALITY OF LIFE AND PAIN OUTCOMES FOLLOWING VIDEO-ASSISTED THORACIC SURGERY (VATS) LOBECTOMY VERSUS THORACOTOMY AND LOBECTOMY
Purpose :

The goal of this study is to see if different types of lung cancer surgery have different effects on the quality of patients' lives. The findings of this study may help doctors understand if surgery with smaller incisions influences the level of postoperative pain and overall quality of life. Investigators hope this study will provide important information that can be used to develop programs to improve the quality of life of patients with lung cancer who undergo surgery.

Two groups of patients with known or suspected early-stage lung cancer may take part in this study. One group includes patients undergoing a video-assisted procedure in which three small, non-rib-spreading incisions are made to remove a lobe of the affected lung (VATS lobectomy). The other group consists of patients who will have a single, rib-spreading incision to remove the affected lobe (thoracotomy and lobectomy). Both groups will complete quality of life and pain questionnaires before, soon after, and up to a year after surgery. The results of the questionnaires will be compared between the two groups.

Eligibility :

To be eligible for this study, patients must meet several criteria, including but not limited to the following:

  • Patients must have known or suspected stage I non-small cell lung cancer and be candidates for lobectomy.
  • Patients may not have had prior therapy, including surgery for the current lesion, systemic chemotherapy, or external beam radiation therapy.

For more information and to see if you are eligible for this study, please contact Dr. Bernard J. Park at 212-639-8874.

Bookmark and SharePrintEmail This Page